Filing Flows

Filing Flows › Cardlytics (CDLX) › Guidance & outlook

Cardlytics (CDLX) guidance and outlook

Cardlytics (CDLX) gave its guidance on Nov 5, 2026: Revenue −31% to −23% for Q4 2026. Cardlytics' 10-Q filed Nov 5, 2026 makes 5 forward-looking statements.

Guidance and outlook

Cardlytics: what its forward-looking statements are about (10-Q filed 2026-11-05)Cardlytics: what its forward-looking statements are about (10-Q filed 2026-11-05)Other3Products1Demand1
5 statements; tone +0.20 (−1 all cautious, +1 all confident); 1 hedged.
Cardlytics: outlook statements against the filing beforeCardlytics: outlook statements against the filing beforeConfident1

Latest guidance

MetricPeriodRangeChange
RevenueQ4 2026−31% to −23%new

From the earnings release filed Nov 5, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 5, 2026

Cardlytics' latest quarter

Cardlytics, Q3 2026: revenue $32.9M (-30% year over year), operating margin -16.5%, net loss $8.9M, operating cash flow −$5.9M. The chart follows the revenue to costs, profit and cash.

Questions

Did Cardlytics raise or lower its guidance?

Cardlytics (CDLX) gave its guidance on Nov 5, 2026: Revenue −31% to −23% for Q4 2026.

What does Cardlytics expect?

We operate a purchase intelligence platform that transforms transaction data into targeted, personalized offers and rewards for consumer brands, delivered through a banking and commerce platform in the United States and the United Kingdom. Working with an advertiser, we design a campaign that targets consumers based on their verified purchase history, including total-wallet visibility into competitive and cross-category spending. We run campaigns offering compelling Consumer Incentives to drive an expected rate of return on advertising spend for marketers.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.